Key factors to consider for rare disease/orphan drug development
Key factors to consider for rare disease/orphan drug development Rare disease clinical trials pose challenges above and beyond those encountered in trials involving more common conditions including: very few patients being available for clinical trials, those who are available are often geographically dispersed, lack of knowledge and data about a particular rare disease, the amount and quality of data generated by small-scale trials and
World Cancer Day 2021: Cromos Pharma is committed to supporting clinical research to make cancer breakthroughs
World Cancer Day 2021: Cromos Pharma is committed to supporting clinical research to make cancer breakthroughs Each 4th February, #WorldCancerDay aims to raise awareness of the global personal, social and economic burden of cancer. It promotes better understanding of cancer and highlights risk factors and ways in which we can all reduce our chances of certain cancers. It advocates for continued clinical research into cancers and effective therapies and treatments. Global Cancer Stats:
Cromos Pharma offers EU Legal Representative Service
Cromos Pharma offers EU Legal Representative Service As part of our full suite of clinical trials solutions, Cromos Pharma provides a European Union Legal Representative service to sponsors who do not have a registered office in the EU/EEA. The Legal Representative acts as the sponsor’s agent in any legal proceedings initiated in the EU / EEA regarding clinical trials and ensures that the

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us